Allergy Therapeutics plc (LON:AGY - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as GBX 6.60 ($0.08) and last traded at GBX 6.30 ($0.08), with a volume of 370347 shares traded. The stock had previously closed at GBX 6.40 ($0.08).
Allergy Therapeutics Price Performance
The company has a current ratio of 1.40, a quick ratio of 1.48 and a debt-to-equity ratio of 37.22. The company has a fifty day moving average price of GBX 5.41 and a two-hundred day moving average price of GBX 5.04. The firm has a market cap of £300.51 million, a P/E ratio of -105.00, a PEG ratio of -30.70 and a beta of 1.40.
Allergy Therapeutics Company Profile
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Further Reading
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
